Abbott to buy Chile’s CFR for $3bn


US medical products specialist Abbott has agreed to buy Chilean generic drugmaker CFR Pharmaceuticals for $2.9 billion (£1.7 billion), and will take on $430 million of CFR’s debt.

The move will bolster Abbott’s position in the rapidly growing markets of Latin America, expanding the company by around 7000 employees at R&D and manufacturing facilities in Chile, Colombia, Peru and Argentina. Abbott will also get access to CFR’s portfolio of over 1000 branded generic drugs and other products, as well as its distribution networks across the region.


Related Content

PPG to buy Mexican paints firm Comex

1 July 2014 Business

news image

$2.3bn deal expands US firm’s footprint in Central America

Rockwood to pay C$720m for lithium firm

28 August 2012 Business

news image

The chemical group has struck a deal to buy Talison, an Australian lithium producer with headquarters in Perth.

Most Read

Perovskite solar cells show hydrogen production promise

26 September 2014 Research

news image

Highly efficient solar cells and catalysts made from cheap, common materials use sunlight to split water

Big name coffee chains drawn into acrylamide fight

23 September 2014 News and Analysis

news image

Starbucks and other coffee chains are being sued in California by a non-profit that wants carcinogen labels slapped on their ...

Most Commented

Perovskite solar cells show hydrogen production promise

26 September 2014 Research

news image

Highly efficient solar cells and catalysts made from cheap, common materials use sunlight to split water

First interstellar sighting of a branched alkyl molecule

25 September 2014 Research

news image

Discovery shows that stellar nurseries could hold amino acids too that might have been the spark for life on Earth